Evidence map›Paper›PMID 28194107›Full record

ArticleFrontiers in pharmacology2016

Both Phenolic and Non-phenolic Green Tea Fractions Inhibit Migration of Cancer Cells.

Ean-Jeong Seo, Ching-Fen Wu, Zulfiqar Ali, Yan-Hong Wang, Shabana I Khan, Larry A Walker, Ikhlas A Khan, Thomas Efferth

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Green Tea (Foods (Basel, Switzerland) · 2021
    Article
  6. Review
  7. Article
  8. Article
  9. Vitamin KInvestigational new drugs · 2020
    Article
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ean-Jeong SeoDepartment of Pharmaceutical Biology, Institute of Pharmacy and Biochemistry, Johannes Gutenberg University Mainz, Germany.
Ching-Fen WuDepartment of Pharmaceutical Biology, Institute of Pharmacy and Biochemistry, Johannes Gutenberg University Mainz, Germany.
Zulfiqar AliNational Center for Natural Products Research, School of Pharmacy, University of Mississippi Oxford, MS, USA.
Yan-Hong WangNational Center for Natural Products Research, School of Pharmacy, University of Mississippi Oxford, MS, USA.
Shabana I KhanNational Center for Natural Products Research, School of Pharmacy, University of MississippiOxford, MS, USA; Department of BioMolecular Sciences, School of Pharmacy, University of MississippiOxford, MS, USA.
Larry A WalkerNational Center for Natural Products Research, School of Pharmacy, University of MississippiOxford, MS, USA; Department of BioMolecular Sciences, School of Pharmacy, University of MississippiOxford, MS, USA.
Ikhlas A KhanNational Center for Natural Products Research, School of Pharmacy, University of MississippiOxford, MS, USA; Department of BioMolecular Sciences, School of Pharmacy, University of MississippiOxford, MS, USA.
Thomas EfferthDepartment of Pharmaceutical Biology, Institute of Pharmacy and Biochemistry, Johannes Gutenberg University Mainz, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Green tea consumption is associated with chemoprevention of many cancer types. Fresh tea leaves are rich in polyphenolic catechins, which can constitute up to 30% of the dry leaf weight. While the polyphenols of green tea have been well investigated, it is still largely unknown, whether or not non-phenolic constituents also reveal chemopreventive and anti-metastatic effects. In this study, we investigated the effects of a fraction of green tea rich in phenolic compounds (PF), a non-phenolic fraction (NPF), which contains glyceroglycolipids (GGL), and a pure glyceroglycolipid compound isolated from the non-phenolic fraction in human cancer. Dried green tea leaves were extracted and applied to a Sephadex LH-20 column. The resazurin reduction assay was used to investigate the cytotoxicity of green tea samples toward human HepG2 hepatocellular carcinoma and normal AML12 hepatocytes cells. Gene expression profiling was performed by mRNA microarray hybridization and the microarray results were validated by RT-PCR. The scratch migration assay was used to investigate the effects of green tea samples on cell migration

Indexed as

chemopreventiongreen teamicroarraynutrigenomicstheaceae

Identifiers

PMID28194107
PMCPMC5278262

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.